A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.

A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan.

Increased re-hospitalization due to acute decompensated heart failure (ADHF) is a modern issue in cardiology. The aim of this study was to investigate risk factors for re-hospitalization due to worsening heart failure, and the effect of tolvaptan (TLV) on decreasing the number of re-hospitalizations...

Full description

Bibliographic Details
Main Authors: Hideyuki Takimura, Tasuku Hada, Mami Kawano, Takayuki Yabe, Yukako Takimura, Satoru Nishio, Masatsugu Nakano, Reiko Tsukahara, Toshiya Muramatsu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6235362?pdf=render

Internet

http://europepmc.org/articles/PMC6235362?pdf=render

Similar Items